Related Experiment Videos
Increased NO production in lysinuric protein intolerance
L Mannucci1, F Emma, M Markert
1Division of Nephrology, Bambino Gesù Children's Hospital and Research Institute, Rome, Italy.
Journal of Inherited Metabolic Disease
|May 7, 2005
Summary
Lysinuric protein intolerance (LPI), a genetic disorder, involves abnormal amino acid transport. This study found increased nitrite/nitrate levels in LPI patients, suggesting a link to the NO-citrulline pathway.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Lysinuric protein intolerance (LPI) is a rare genetic disorder affecting dibasic amino acid transport due to SLC7A7 gene mutations.
- LPI presents with renal failure, pulmonary alveolar proteinosis, and autoimmune symptoms, often with elevated plasma citrulline.
- The precise mechanisms underlying LPI's complex clinical manifestations remain incompletely understood.
Purpose of the Study:
- To investigate the role of the nitric oxide (NO) pathway in LPI.
- To measure plasma and urinary nitrite/nitrate (NO2-/NO3-) concentrations in LPI patients.
- To assess in vitro NO2- production in cultured fibroblasts from LPI patients.
Main Methods:
- Analysis of plasma and urinary NO2-/NO3- levels in three LPI patients.
- Measurement of NO2- release in the culture medium of LPI patient-derived fibroblasts.
- Correlation of biochemical findings with known LPI clinical features.
Main Results:
- Elevated plasma NO3- concentrations were observed in LPI patients.
- Increased NO2- release was detected in the medium of cultured LPI fibroblasts.
- These findings suggest alterations in NO metabolism associated with LPI.
Conclusions:
- The study identifies increased NO3- levels and enhanced NO2- production in LPI.
- A potential link between the NO-citrulline pathway and LPI pathogenesis is proposed.
- This research may offer new insights into the poorly understood clinical signs of LPI.